A detailed history of Virtus Fund Advisers, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 732 shares of EXAS stock, worth $38,730. This represents 0.24% of its overall portfolio holdings.

Number of Shares
732
Previous 732 -0.0%
Holding current value
$38,730
Previous $30,000 63.33%
% of portfolio
0.24%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $1,322 - $2,376
32 Added 4.57%
732 $30,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $39,389 - $51,639
700 New
700 $48,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.